医思健康2021/22半年度业绩报告

Corporate Information公司資料2Geographical Coverage地域覆蓋4Financial Highlights財務摘要5Management Discussion and Analysis管理層討論及分析7Other Information其他資料29Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及 其他全面收益表44Consolidated Statement of Financial Position綜合財務狀況表45Consolidated Statement of Changes in Equity綜合權益變動表47Condensed Consolidated Statement of Cash Flows簡明綜合現金流量表48Notes to the Interim Financial Statements中期財務報表附註49Definition釋義73目錄CONTENTSThis Interim Report is printed on environmentally friendly paper本中期業績報告以環保紙張印刷 2CORPORATE INFORMATION公司資料EC Healthcare INTERIM REPORT 2021/22DIRECTORSExecutive DirectorsTANG Chi Fai (Chairman & Chief Executive Officer)LU Lyn Wade Leslie (Co-Chief Executive Officer) (appointed on 23 August 2021)LEE Heung Wing (Chief Financial Officer)WONG Ka Ki Ada (Chief Strategy Officer & Chief Investment Officer) (appointed on 11 October 2021)WONG Chi Cheung (Chief Digital Officer)LEE Gabriel (Chief Operating Officer) (resigned on 1 October 2021)Non-Executive DirectorsLUK Kun Shing Ben (Chief Information Officer)Dr. WANG Steven Dasong (resigned on 19 July 2021)Independent Non-Executive DirectorsMA Ching NamLOOK AndrewLAM Chi Hang JosekinAUDIT COMMITTEELOOK Andrew (Chairman)MA Ching NamLAM Chi Hang JosekinNOMINATION COMMITTEETANG Chi Fai (Chairman)LAM Chi Hang JosekinLOOK AndrewREMUNERATION COMMITTEELAM Chi Hang Josekin (Chairman)MA Ching NamLOOK AndrewCOMPANY SECRETARYSIU Chun Pong RaymondAUTHORISED REPRESENTATIVESLEE Heung WingSIU Chun Pong RaymondSTOCK CODE2138COMPANY’S WEBSITEwww.echealthcare.com董事執行董事鄧志輝（主 席及行政總裁）呂聯煒（聯 席行政總裁） （於 二零二一年八月二十三日獲委任）李向榮（首 席財務官）王家琦（首 席策略總監及首席投資總監） （於 二零二一年十月十一日獲委任）黃志昌（首 席數碼官）李嘉豪（營 運總監）（於 二零二一年十月一日辭任）非執行董事陸韵晟（資 訊科技總監）王大松博士（於 二零二一年七月十九日辭任）獨立非執行董事馬清楠陸東林知行審核委員會陸東（主 席）馬清楠林知行提名委員會鄧志輝（主 席）林知行陸東薪酬委員會林知行（主 席）馬清楠陸東公司秘書蕭鎮邦授權代表李向榮蕭鎮邦股份代號2138公司網站www.echealthcare.com 3醫思健康2021/22 中期業績報告CORPORATE INFORMATION公司資料PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICEConyers Trust Company (Cayman) LimitedCricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman IslandsHONG KONG SHARE REGISTRARLink Market Services (Hong Kong) Pty LimitedSuite 1601, 16/F, Central Tower28 Queen’s Road CentralHong KongREGISTERED OFFICECricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman IslandsHEADQUARTERS AND PRINCIPAL PLACE OF BUSINESS IN HONG KONGL50Langham Place Office Tower8 Argyle StreetMong KokHong KongLEGAL ADVISERas to Hong Kong lawRaymond Siu & LawyersUnits 1302–3 & 1802, Ruttonjee House11 Duddell StreetCentral, Hong Kongas to PRC LawZhong Lun Law Firm8–10/F, Tower A, Rongchao Tower, 6003 Yitian Road, Futian District, Shenzhen 518026, P.R.ChinaAUDITORKPMGCertified Public AccountantsPublic Interest Entity Auditor registered in accordance with the Financial Reporting Council Ordinance8th FloorPrince’s Building10 Chater RoadCentralHong Kong主要證劵登記處Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman Islands香港證券登記處Link Market Services (Hong Kong) Pty Limited香港皇后大道中28號中匯大廈16樓1601室註冊辦事處Cricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman Islands香港總部及主要營業地點香港旺角亞皆老街8號朗豪坊辦公大樓50樓法律顧問香港法律蕭鎮邦律師行香港中環都爹利街11號律敦治大廈1302–3及1802室中國內地法律中倫律師事務所中國深圳市福田區益田路6003號榮超商務中心A棟8–10層，郵 編518026核數師畢馬威會計師事務所執業會計師根據《財 經匯報條例》 註冊的 公眾利益實體核數師香港中環遮打道10號太子大廈8樓 4GEOGRAPHICAL COVERAGE地域覆蓋EC Healthcare INTERIM REPORT 2021/22Shenzhen 深圳 (8)Guangzhou 廣州 (5)Macau 澳門 (2)Zhuhai珠海Zhaoqing肇慶Guangzhou廣州Huizhou惠州Dongguan東莞Foshan佛山Shenzhen深圳Jiangmen江門Zhongshan中山THE GREATER BAY AREA大灣區Hong Kong香港Chongging 重慶 (1)Shanghai 上海 (1)Hong Kong 香港 (74)CHINA中國( ) number of service centres/clinics( ) 服 務中心╱診 所數目 5醫思健康2021/22 中期業績報告FINANCIAL HIGHLIGHTS財務摘要For the six months ended30 September截至九月三十日止六個月20212020Change二零二一年二零二零年變動 Revenue收入1,443,680,390797,366,81581.1%EBITDA(1)息稅折舊及攤銷前之盈利(1)323,427,483114,926,540181.4%Profit before tax除稅前溢利231,718,21960,871,916280.7%Profit for the period期內溢利196,064,75653,303,917267.8%Profit attributable to owners of the Company本公司擁有人應佔溢利160,207,60043,928,321264.7%Basic earnings per share (HK Cents)每股股份基本盈利（港 仙）14.24.4222.7% As at30 September 2021As at31 March2021Change於二零二一年九月三十日於二零二一年三月三十一日變動 Total assets資產總值4,542,552,2913,790,481,54319.8%Total liabilities負債總額2,046,211,2892,159,695,901-5.3%Net assets資產淨值2,496,341,0021,630,785,64253.1% For the six months ended30 September截至九月三十日止六個月20212020二零二一年二零二零年 Financial Metrics財務指標EBITDA Margin (2)息稅折舊及攤銷前之盈利率(2)22.4%14.4%Net profit margin(3)淨溢利率(3)13.6%6.7%Dividend per share (HK cents)每股股息（港 仙）10.2 HK cents港仙3.0 HK cents港仙 6EC Healthcare INTERIM REPORT 2021/22FINANCIAL HIGHLIGHTS財務摘要附註：1. 息稅折舊及攤銷前之盈利等於未計利息、 稅項、 自有物業、 廠房及設備折舊及攤銷前的盈利。 息稅折舊及攤銷前之盈利並非香港財務報告準則下的標準計量方法。 本公司管理層認為， 息稅折舊及攤銷前之盈利作為本集團業務所得經營現金流的代表， 為投資者提供有用的補充資料，以 評估本集團的表現。下表載列於所示期間息稅折舊及攤銷前之盈利與除稅前溢利的對賬：2. 息稅折舊及攤銷前之盈利率等於財政年度內未計利息、稅項、 自有物業、 廠房及設備折舊及攤銷前的盈利除以總收入。3. 淨溢利率等於所示期間溢利除以同期的收入。Notes:1. EBITDA equals earnings before interests, taxation, depreciation-owned property, pl